Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,490 across all filing types
Latest filing 2024-05-24 AGM Information
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
NOTICE OF THE ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice for the Annual General Meeting (AGM) of 3SBio Inc., detailing the date, agenda items including adoption of audited financial statements, re-election of directors, dividend declaration, re-appointment of auditors, and approval of share issuance and repurchase mandates. It is clearly labeled as a "NOTICE OF THE ANNUAL GENERAL MEETING" and contains procedural information for shareholders to attend and vote. There is no actual financial data or report content, only the announcement and agenda for the AGM. Therefore, this document fits the category of AGM Information (AGM-R).
2024-05-24 English
GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, DECLARATION AND PAYMENT OF FINAL DIVIDEND OUT OF THE SHARE PREMIUM ACCOUNT OF THE COMPANY AND NOTICE OF ANNUAL GENERAL MEETIN
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a circular from 3SBio Inc. dated 24 May 2024, containing detailed information about the upcoming Annual General Meeting (AGM) scheduled for 25 June 2024. It includes proposals for general mandates to issue and repurchase shares, re-election of directors, declaration and payment of final dividend, and the notice of the AGM itself. The document contains a letter from the board, explanatory statements, details of directors for re-election, and the proxy form. It is not a financial report, earnings release, or audit report, but rather a comprehensive meeting circular with agenda items and voting information. This type of document is best classified as Proxy Solicitation & Information Statement (PSI), as it is sent to shareholders to provide information and request votes for the AGM.
2024-05-24 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for 3SBio Inc. It details repurchases of shares on various dates, quantities, prices, and confirms compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and changes in issued shares, with no financial statements or earnings data. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is over 12,000 characters and contains detailed transactional data, not just an announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2024-05-16 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by 3SBio Inc. It details repurchases of shares on various dates, quantities, and prices, confirming compliance with listing rules. The content focuses on share repurchase activities and capital changes rather than financial results, management commentary, or regulatory certifications. The document length is over 12,000 characters and contains detailed transactional data on share repurchases. This matches the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-05-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 April 2024. It details movements in authorized and issued shares, share options, repurchases, and confirmations related to share capital. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital movements and share repurchases. It does not contain financial statements, earnings data, or management discussion. It is not an annual or interim report, nor an earnings release or investor presentation. It is a regulatory filing reporting share capital movements and related confirmations, fitting the category of Regulatory Filings (RNS). The document length (7426 characters) and detailed tabular data support this classification rather than a brief announcement or a report publication announcement.
2024-05-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2024
Regulatory Filings Classification · 95% confidence The document is a monthly return report detailing movements in authorised and issued share capital for Hongkong Chinese Limited, including share capital balances and confirmations. It is submitted to the Hong Kong Exchanges and Clearing Limited and relates to share capital changes and securities movements. The document is not a full financial report, earnings release, or management discussion. It is a regulatory filing reporting share capital status and movements, typical of compliance and disclosure requirements under exchange rules. The document length is 4465 characters, which is relatively short and focused on share capital data rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general compliance disclosure rather than a specific capital change announcement or share issue notice, since no new shares were issued or repurchased during the period.
2024-05-02 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.